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Although N-acetylcysteine (NAC) has been shown to be neuroprotective for traumatic brain injury (TBI), the mechanisms for this
beneﬁcial eﬀect are still poorly understood. Cerebral inﬂammation plays an important role in the pathogenesis of secondary brain
injury after TBI. However, it has not been investigated whether NAC modulates TBI-induced cerebral inﬂammatory response.
In this work, we investigated the eﬀect of NAC administration on cortical expressions of nuclear factor kappa B (NF-κB) and
inﬂammatory proteins such as interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and intercellular
adhesion molecule-1 (ICAM-1) after TBI. As a result, we found that NF-κB, proinﬂammatory cytokines, and ICAM-1 were
increasedinallinjuredanimals.InanimalsgivenNACpost-TBI,NF-κB,IL-1β,TNF-α,andICAM-1weredecreasedincomparison
to vehicle-treated animals. Measures of IL-6 showed no change after NAC treatment. NAC administration reduced brain edema,
BBB permeability, and apoptotic index in the injured brain. The results suggest that post-TBI NAC administration may attenuate
inﬂammatory response in the injured rat brain, and this may be one mechanism by which NAC ameliorates secondary brain
damage following TBI.
Copyright © 2008 Gang Chen et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Although traumatic brain injury (TBI) represents a signiﬁ-
cant public health problem in the world, there are currently
no treatments that improve clinical outcome measures
[1, 2]. Recently, several reports from experimental studies
have demonstrated that N-acetylcysteine (NAC) played
neuroprotective roles in TBI including restoration of TBI-
induced mitochondrial dysfunction, increasing the reduced
antioxidant enzyme, and protecting neurons [3–5]. Most of
these previous studies focused on the modulation of NAC
on oxidative stress in the brain following TBI, but ignored
the inﬂuence of NAC on cerebral inﬂammation, which also
played crucial roles in the mechanisms of secondary brain
damage after TBI [6]. Furthermore, no study was found in
the literature to investigate the eﬀects of NAC administration
on brain edema, blood-brain barrier (BBB) permeability,
and cortical apoptosis following TBI.
Several clinical and experimental studies have demon-
strated that secondary brain injury can be magniﬁed by
numerous immune mediators, which are frequently upreg-
ulated in response to TBI [7–9]. Increased levels of these
molecules within the injured brain, including interleukin-
1β (IL-1β), tumor necrosis factor-α (TNF-α), interleukin-6
(IL-6), and intercellular adhesion molecule-1 (ICAM-1), are
believed to contribute to the cerebral damage, cell death, and
BBB dysfunction [10]. A pivotal player in the regulation of
these molecules is the nuclear factor kappa B (NF-κB) family
(cRel, RelA/p65, RelB, p50 and p52) of transcription factors
[11, 12]. In our previous studies, we have demonstrated that
cortical contusion trauma could induce a concomitant and
persistent upregulation of NF-κB, TNF-α,I L - 6 ,a n dI C A M - 1
intheinjuredratbrain,whichmightplayacentralroleinthe
injury-induced inﬂammatory response of brain [13, 14].
NAC is a compound that increases the pool of glu-
tathione. The latter is an important cellular antioxidant.2 Mediators of Inﬂammation
It is a reactive oxygen species (ROS) scavenger and can
restore the reduced cellular glutathione [15]. It is also
cytoprotective since it inhibits the activation of NF-κBa n d
TNF-α production by lipopolysaccharide [16, 17]. Xiong
et al. have reported that NAC could greatly restore brain
glutathione levels and mitochondrial glutathione levels after
TBI [3]. Also, in a rat model of experimental stroke,
administration of NAC after ischemia onset protected the
brain from free radical injury, apoptosis, and inﬂammation,
with a wide treatment window [18]. Nevertheless, it is still
unknownuptillnowwhetherNACcanaﬀecttheproduction
of inﬂammatory agents in the brain after TBI.
The aim of the current study was to determine whether
NACcouldattenuatetheTBI-inducedbraininﬂammationin
the pericontusional area. We hypothesized that the eﬀect of
NAC on modulating cerebral inﬂammatory response might
be a mechanism by which NAC reduced cerebral edema,
protected BBB, and repressed cortical apoptosis after TBI.
2. MATERIALS AND METHODS
2.1. Animals
Male Wistar rats (250–300g) were purchased from Animal
Center of Chinese Academy of Sciences, Shanghai, China.
The rats were housed in temperature and humidity con-
trolled animal quarters with a 12-hour light/dark cycle. All
procedures were approved by the Institutional Animal Care
Committeeandwereinaccordancewiththeguidelinesofthe
National Institutes of Health on the care and use of animals.
2.2. Experimentprotocol
Rat model of cortical contusion trauma: following IP anes-
thesia with urethane (1000mg/kg), animal head was ﬁxed in
the stereotactic frame. A right parietal craniotomy (diameter
5mm) was drilled under aseptic conditions 1mm posterior
and 2mm lateral to the bregma. We used a modiﬁcation
of Feeney’s weight-drop model in which a freefalling weight
ontotheexposedintactcranialduraproducedastandardized
parietal contusion by letting a steel rod weighing 40g with a
ﬂat end diameter of 4mm fall onto a piston resting on the
d u r af r o mah e i g h to f2 5c m[ 19]. The piston was allowed
to compress the tissue a maximum of 5mm. After operation
procedures,theratswerethenreturnedtotheircagesandthe
roomtemperaturekeptat23 ±1◦C.Heartrate,arterialblood
pressure, and rectal temperature were monitored, and the
rectal temperature was kept at 37 ± 0.5◦C, by using physical
cooling (ice bag) when required, throughout experiments.
Sham-operated rats were anesthetized and mounted in
the stereotactic apparatus, with right parietal craniotomy
surgically prepared alone and without brain injury.
We established 3 experimental groups in a randomized
fashion: (a) the sham operation group (SHAM; n = 15), (b)
the TBI group (TBI; n = 18), and (c) the NAC treatment
group (TBI-NAC; n = 18). Rats of TBI-NAC group received
injections of 150mg/kg NAC IP at 15 minutes and 1, 2, and 3
daysafterthesurgery.RatsofSHAMandTBIgroupsreceived
equal volumes of 0.9% saline solution. The dose was chosen
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Figure 1: Schematic representation of the cortical contusion
area induced by weight-dropping trauma and the studied region
surrounding the injured brain.
according to Hicdonmez et al. since they observed beneﬁcial
eﬀects on preventing trauma-induced oxidative brain tissue
damage following TBI after treatment with NAC using the
same protocol [4]. The animals were decapitated 3 days after
injury for tissue assays. The surrounding brain tissue of the
injuredcortex(seeFigure 1)wasdissectedoniceasdescribed
in our previous study [14], some of which were put into 10%
buﬀered formalin, the others were stored at liquid nitrogen
immediately until use.
2.3. Nuclearproteinextractandelectrophoretic
mobilityshiftassay(EMSA)
Nuclear protein was extracted and quantiﬁed as described
[14, 20]. EMSA was performed using a commercial kit (Gel
Shift Assay System; Promega, Madison, Wis, USA) following
the methods in our laboratory. The NF-κBo l i g o n u c l e o t i d e
probe (5 -AGTTGAGGGGACTTTCCCAGGC-3 ) was end-
labeled with [γ-32P] ATP (Free Biotech, Beijing, China).
EMSA was performed according to our previous study [14,
20].
2.4. Enzyme-linkedimmunosorbentassay(ELISA)
The levels of inﬂammatory mediators were quantiﬁed using
speciﬁc ELISA kits for rats according to the manufacturers’
instructions (TNF-α from Diaclone Research, Besanc ¸on,
France; IL-1β, IL-6 from Biosource Europe SA, Nivelles,
Belgium) and our previous studies [14, 20]. Values were
expressed as ng/g protein.
2.5. Immunohistochemicalstudy
Immunohistochemical studies were conducted on formalin-
ﬁxed, paraﬃn-embedded sections. The rabbit-antirat mon-
oclonal antibody of ICAM-1 (diluted 1:100, Santa Cruz
Biotechnology, Calif, USA) was used. ImmunohistochemicalGang Chen et al. 3
assay was performed according to our previous study [14].
The positive cells were identiﬁed, counted, and analyzed
under the light microscope by an investigator blinded to
the grouping. The number of positive microvessels in each
section was counted in 10 microscopic ﬁelds (at × 100 mag-
niﬁcations) and averaged for the positively immunostained
vessel number of per visual ﬁeld.
2.6. Brainwatercontent
Brain edema was determined using the wet/dry method as
previously described where the percentage of brain water =
[(wetweight −dryweight)/wetweight] ×100%[21].Brieﬂy,
brains were rapidly removed from the skull and the bilateral
brains were separated. Both were placed separately into
preweighed and labeled glass vials and weighed. The vials
w e r et h e np l a c e di na no v e nf o r7 2h o u r sa t1 0 0 ◦Ca n d
then reweighed to obtain dry weight content. The number
of animals used in each group for brain edema study was as
follows: for SHAM (n = 5), for TBI (n = 6), and for TBI-NAC
(n = 6).
2.7. Blood-brainbarrierpermeability
Blood-brain barrier (BBB) permeability was determined by
E v a n sb l u e( E B )e x t r a v a s a t i o na t3d a y sa f t e rT B I .B r i e ﬂ y ,
2% Evans blue was injected IV at a dose of 2mL/kg.
Animals were then reanesthetized after 1 hour with urethane
(1000mg/kg) and perfused using saline to remove intravas-
cular EB dye. Animals were then decapitated; the brains were
removed and homogenized in phosphate buﬀered saline.
Trichloroacetic acid was then added to precipitate protein,
and the samples were cooled and centrifuged. The resulting
supernatant was measured for absorbance of EB at 610nm
using a spectrophotometer. The number of animals used in
each group for BBB permeability study was as follows: for
SHAM (n = 5), for TBI (n = 6), and for TBI-NAC (n = 6).
2.8. TUNELstainingandquantitation
ofapoptoticcells
The formalin-ﬁxed tissues were embedded in paraﬃna n d
sectioned at 4μm thickness with a microtome. The sections
were detected for apoptotic cells by terminal deoxynu-
cleotidyl transferase-mediated dUTP nick end labeling
(TUNEL) method. TUNEL: in situ cell death detection kit
POD (ISCDD, Boehringer Mannheim, Germany) was used.
The procedures were according to the protocol of the kit and
our previous study [14]. The positive cells were identiﬁed,
counted, and analyzed under the light microscope by an
investigator blinded to the grouping. The extent of brain
damage was evaluated by apoptotic index which was the
average number of TUNEL-positive cells in each section
counted in 10 microscopic ﬁelds (at ×200 magniﬁcations).
2.9. Statisticalanalysis
Alldatawerepresentedasmean ±SD.SPSS12.0wasusedfor
statistical analysis of the data. All data were subjected to one-
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Figure 2: NF-κB activity in the brain area surrounding the injury
siteinSHAMgroup(n=5),TBIgroup(n=6),andTBI-NACgroup
(n = 6). (Upper) EMSA autoradiography of NF-κB DNA binding
activity. (Bottom) levels of NF-κB DNA binding activity quantiﬁed
by computer-assisted densitometric scanning and expressed as
arbitrary densitometric units (ADUs). As compared with SHAM
group, NF-κB binding activity measured by EMSA was signiﬁcantly
increased in TBI group. Compared to TBI group, NAC signiﬁcantly
suppressed NF-κBa c t i v a t i o ni nT B I - N A Cg r o u p .∗∗P<. 01 versus
SHAM group, ##P<. 01 versus TBI group.
way ANOVA. Diﬀerences between experimental groups were
determined by Fisher’s LSD posttest. Statistical signiﬁcance
was inferred at P < .05.
3. RESULTS
3.1. EMSAforNF-κB
EMSA autoradiography of NF-κB DNA binding activity of
the injured brain samples was shown in Figure 2.L o wN F - κB
binding activity (weak EMSA autoradiography) was found
in the SHAM group. Compared with SHAM group, NF-
κB binding activity in the injured brain was signiﬁcantly
increased (P < .01) in TBI group. In TBI-NAC group, the
NF-κB binding activity was signiﬁcantly downregulated (P <
.01) in the brain area surrounding the injury site after TBI.
3.2. ConcentrationsofIL-1β,TNF-α,andIL-6
intheinjuredbrains
Concentrations of IL-1β,T N F - α, and IL-6 were low in the
rat brains of SHAM group (6.16 ± 1.63, 0.58 ± 0.20, and
0.19 ± 0.03ng/g protein, resp.) (see Figure 3). Compared
with SHAM group, cortical levels of the three inﬂammatory
cytokines were greatly induced after TBI (P < .01). As shown
in Figure 3, NAC administration after TBI could lead to4 Mediators of Inﬂammation
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Figure 3: Changes of inﬂammatory mediators in the injured brains
as determined by ELISA in SHAM group (n = 5), TBI group (n =
6), and TBI-NAC group (n = 6). TBI could induce the signiﬁcantly
increased concentrations of IL-1β,T N F - α, and IL-6 in the rat
brain surrounding the injury site. In TBI-NAC group, the cortical
concentrations of IL-1β and TNF-α but not IL-6 were markedly
downregulated as compared with that of TBI group. ∗∗P<. 01
versus SHAM group; #P<. 05 and ##P<. 01 versus TBI group.
signiﬁcantly decreased IL-1β and TNF-α concentrations, but
had no signiﬁcant eﬀect on the IL-6 concentration (P > .05)
in rat brain tissue.
3.3. ICAM-1expressioninthevesselsofinjuredbrain
As shown in Figure 4(a), few ICAM-1-immunostained cere-
bral microvessels were observed in the SHAM group rat
brain. In TBI group, the number of ICAM-1-positive vessels
was signiﬁcantly increased as compared with that in the
SHAM group (P < .01) (see Figures 4(b) and 4(d)). In TBI-
NACgroup,whencomparedwiththeTBIgroup,thenumber
of ICAM-1-positive vessels was signiﬁcantly decreased (P <
.05) (see Figures 4(c) and 4(d)). The results showed that
systemic injections of NAC could signiﬁcantly downregulate
the ICAM-1 immunoreactivity in the vessels of injured brain
(see Figure 4(d)).
3.4. Brainwatercontent
Signiﬁcant increase (P < .01) in water content was detected
in the brain samples of injured side at 3 days after TBI when
compared with sham-operated rats (see Figure 5). The mean
valueofbrainwatercontentintheinjuredsidewasdecreased
by NAC administration (P < .01) as compared with TBI
group.Fortheuninjuredside,themeanvaluesofbrainwater
content had no signiﬁcant diﬀerence among SHAM, TBI,
and TBI-NAC groups. The results suggested that post-TBI
NAC treatment could attenuate brain edema in this rat TBI
model.
3.5. Blood-brainbarrierpermeability
The pattern of Evans blue extravasation following TBI is
shown in Figure 6. Rats in TBI group demonstrated a
signiﬁcant increase (P < .01) in BBB permeability to Evans
blue relative to rats of SHAM group. Administration of
NAC signiﬁcantly inhibited Evans blue extravasation (P <
.05), indicating a reduced BBB opening in response to NAC
treatment.
3.6. Apoptosisintheinjuredcortex
Few TUNEL-positive apoptotic cells were found in the
SHAM group rat brain (see Figure 7(a)). In TBI group, the
apoptotic index in the cortex surrounding the injured site
was found to be signiﬁcantly increased compared with that
in SHAM animals (P<. 01) (see Figures 7(b) and 7(d)). In
TBI-NAC group, whencomparedwiththatin theTBIgroup,
the apoptotic index in the studied cortex was signiﬁcantly
decreased (P < .01) (see Figures 7(c) and 7(d)). The result
showed that NAC administration following TBI could lead
lesscelldeathinthebrainsurroundingthecorticalcontusion
and was potential to ameliorate the secondary brain damage
following TBI.
4. DISCUSSION
The main ﬁndings of this study are that (1) as common
inﬂammation-related factors to TBI, NF-κB, proinﬂamma-
tory cytokines, and ICAM-1 were upregulated after TBI and
could be suppressed when treated with NAC and (2) after
NAC administration, the brain edema, BBB permeability,
and apoptotic cell death were ameliorated. These ﬁndings
suggest for the ﬁrst time that NAC attenuates the TBI-
induced cerebral inﬂammatory response and alleviates sec-
ondary brain damage following primary trauma in the rat
TBI model.
There have been several studies focusing on the neu-
roprotective eﬀects of NAC in TBI. As mentioned by Ellis
et al. in their literature, NAC could direct scavenge radicals
and stimulate glutathione peroxidase activity in a cat TBI
model [22]. Their results suggested that NAC might be
useful for treatment of oxygen-free radical-mediated brain
injury. Another research indicated that NAC administered
postinjury at an early stage could eﬀectively restore TBI-
induced mitochondrial dysfunction and the protective eﬀect
of NAC might be related to its restoration of glutathione
levels in the brain [3]. More recent data revealed by
Hicdonmez et al. was that NAC treatment after trauma was
eﬀective in lipid peroxidation, antioxidant enzyme activity,
and neuronal protection in cerebral injury following closed
head trauma [4]. In this current study, we found that
NAC administration following TBI could reduce cerebral
edema, BBB permeability, and apoptotic cell death whichGang Chen et al. 5
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Figure 4: ICAM-1 immunohistochemistry in the injured cortex in SHAM group (n = 5 ) ,T B Ig r o u p( n = 6), and TBI-NAC group (n = 6).
(a) SHAM rats showing few ICAM-1 positive vessels. (b) TBI rats showing strong ICAM-1 positive vessels stained as brown. (c) TBI-NAC
rats showing less ICAM-1 positive vessels than TBI rats (scar bar, 50μm). (d) Administration of NAC remarkably inhibited TBI-induced
upregulation of ICAM-1 expression on cerebrovascular endothelia. ∗∗P<. 01 versus SHAM group; #P<. 05 versus TBI group.
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Figure 5: Alterations in brain water content in SHAM group (n =
5), TBI group (n = 6), and TBI-NAC group (n = 6). The brain water
content of the injured side was increased signiﬁcantly at 3 days after
TBI. NAC treatment markedly reduced brain water content. No
diﬀerence of brain water content was detected in the uninjured side
among the three groups. ∗∗P<. 01 versus SHAM group; ##P<. 01
versus TBI group.
played important roles and were the major part in the
secondary brain injury following TBI. However, despite the
demonstratedmechanismsofNACinneuroprotection,none
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Figure 6: Alterations in Evans blue extravasation in SHAM group
(n = 5), TBI group (n = 6), and TBI-NAC group (n = 6). TBI could
induce a marked increase of BBB extravasation in the rat brain
compared with SHAM group. After NAC administration, the Evans
blue extravasation was signiﬁcantly reduced as compared with TBI
group. ∗∗P<. 01 versus SHAM group, #P<. 05 versus TBI group.
of the previous studies focused on cerebral inﬂammatory
response that might facilitate the development of secondary
brain damage following primary trauma.
Brain inﬂammation represents only one of the numerous
processes activated after TBI; it has not been fully elucidated
due to the complexity of the large number of molecules
shaping a sophisticated circuitry. The major eﬀectors in
this cascade are the proinﬂammatory cytokines that are6 Mediators of Inﬂammation
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Figure 7: TUNEL immunohistochemistry staining of the injured cortex in SHAM group (n = 5), TBI group (n = 6), and TBI-NAC group
(n = 6). (a) SHAM group rats showing few TUNEL apoptotic cells. (b) TBI group rats showing more TUNEL apoptotic cells stained
as brown. (c) TBI-NAC group rats showing less TUNEL apoptotic cells than TBI group (scar bar, 50μm). (d) Administration of NAC
signiﬁcantly decreased the apoptotic index in rat injured brain following TBI. ∗∗P<. 01 versus SHAM group; ##P<. 01 versus TBI group.
usually released within minutes after challenge because they
are stored intracellularly as precursor proteins eventually
modiﬁed into active molecules. TBI damages the blood-
brain barrier, then the blood cells such as neutrophils and
macrophages accumulate in the brain and further sustain
the cerebral inﬂammatory cascade [23]. Numerous immune
mediators such as IL-1β,T N F - α, and IL-6 released within
minutes of the primary injury can initiate the inﬁltration of
inﬂammatory cells into the brain by activating ICAM-1 and
other adhesion molecules [14]. The functional importance
of NF-κB in acute inﬂammation is based on its ability to
regulate the promoters of a variety of genes whose products,
such as IL-1β,T N F - α, IL-6, ICAM-1, and acute phase
proteins, are critical to inﬂammatory processes [11]. NF-
κBactivationenhancesthetranscriptionofproinﬂammatory
cytokines, and the cytokines are known to in turn activate
NF-κB[ 24]. The positive feedback is believed to serve to
amplify inﬂammatory signals. In our previous studies, it
has been found that there were an early concomitant and
persistent upregulation of NF-κB binding activity, TNF-α,
IL-6, and ICAM-1 expression in the injured brain after
cortical contusion trauma [13, 14].
A number of studies have demonstrated that NAC could
modulate inﬂammatory factors production such as NF-
κB, proinﬂammatory cytokines, and ICAM-1 [25]. Carroll
et al. examined the inﬂuence of NAC on cerebral NF-κB
activity after temporary middle cerebral artery occlusion and
indicated that activated NF-κB was signiﬁcantly increased
15 minutes after reperfusion in the aﬀected hemisphere
and could be abolished with NAC treatment [25]. Li et al.
investigated eﬀects of NAC on NF-κB activation and proin-
ﬂammatory cytokines production in protein malnutrition
using an animal septic shock model and their results
suggested that supplementation of NAC could normalize
lipopolysaccharide-induced NF-κB activation and proin-
ﬂammatory cytokines production during early rehabilitation
of protein malnourished mice [26]. Our study showed that
cortical levels of NF-κB, TNF-α,I L - 1 β,I L - 6 ,a n dI C A M - 1
were signiﬁcantly induced by TBI at 3 days after trauma.
Post-TBI NAC administration could repress the expressions
of most of these inﬂammatory agents that accompanied TBI.
Although our data have proved that NAC could downreg-
ulate the cerebral inﬂammatory factors after TBI, changes
about the signaling pathways of inﬂammation and oxidativeGang Chen et al. 7
stress in the brain remain unknown. It is assured that further
ingenious studies are needed and will be conducted in our
laboratory.
Apoptosis in the traumatically injured brain occurs not
only at the impact site but also as a result of secondary brain
insults such as intracranial hypertension, hypoxia, or distur-
bances of microcirculation [27]. Studies regarding the eﬀect
of NAC on neural apoptosis after TBI have not been found
to date. Nevertheless, several previous studies have demon-
strated that NAC could prevent apoptotic death of neuronal
cells in vitro [28, 29]. NAC also inhibited procaspase-9
processing and the activation of enzymatic activity of
caspases induced by acrolein. Inhibition of acrolein-induced
apoptosis using NAC was conﬁrmed morphologically by
diminished condensation of nuclear chromatin, as evaluated
by ﬂuorescence microscopy [30]. In this present study,
we found that systemic NAC administration could inhibit
apoptotic cell death in the injured brain and was potential to
reduce the secondary brain damage following TBI. However,
it is still unclear whether NAC can modulate the apoptotic
signals and the whole mechanisms involved call for further
research.
In conclusion, to the best of our knowledge, this is
the ﬁrst study to demonstrate the eﬀect of NAC on the
inﬂammatory response in the injured brain after TBI. We
found that TBI could upregulate the expressions of NF-
κB, IL-1β,T N F - α, and ICAM-1 in the surrounding brain
of injured site, which could be markedly inhibited by
NAC administration. The therapeutic beneﬁt of post-TBI
NAC administration might be due to its salutary eﬀect on
modulating cerebral inﬂammation secondary to TBI.
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